Back to Woodline Partners LP Woodline Partners LP

SGMTSGMT
9 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in SAGIMET BIOSCIENCES INC

Yes. Woodline Partners holds 3,000,652 shares of SGMT (Sagimet Biosciences), worth $23.2M, as of its Q2 2026 13F filing. It increased the position by 1,999,709 shares (+199.8%) from Q1 2026. Woodline Partners has held SGMT since Q2 2025, across 5 quarterly 13F filings. SGMT is 0.1% of Woodline Partners' reported 13F portfolio.

Current Value

$23.2M

Current Shares

3M

Total Value Change

+$20.6M

Total Shares Change

+2.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3M
+199.8%
$23.2M0.1%$7.73
46
2026-Q1
Unchanged
1M
0.0%
$5.2M0.0%$5.62
0
2025-Q4
Decreased
1M
-33.3%
$5.9M0.0%$5.85
0
2025-Q3
Decreased
1.5M
-41.2%
$10.3M0.0%$6.92
0
2025-Q2
New
2.6M
-
$19.5M0.1%$7.87
47
2024-Q2
Exited
0
-100.0%
$00.0%$3.42
0
2024-Q1
Increased
300,170
0.0%
$1.6M0.0%$5.42
26
2023-Q4
Decreased
300,169
0.0%
$1.6M0.0%$5.42
0
2023-Q3
New
300,171
-
$2.6M0.0%$8.80
36

Other major holders of SGMT: BlackRock, Inc., BALYASNY ASSET MANAGEMENT L.P., FMR LLC, VANGUARD CAPITAL MANAGEMENT LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used